MX2017011028A - Combination of a retinoid and a diol and polyunsaturated fatty acid ester. - Google Patents

Combination of a retinoid and a diol and polyunsaturated fatty acid ester.

Info

Publication number
MX2017011028A
MX2017011028A MX2017011028A MX2017011028A MX2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A MX 2017011028 A MX2017011028 A MX 2017011028A
Authority
MX
Mexico
Prior art keywords
combination
retinoid
diol
fatty acid
acid ester
Prior art date
Application number
MX2017011028A
Other languages
Spanish (es)
Inventor
Redoules Daniel
Castex-Rizzi Nathalie
Hilaire Saurat Jean-
BESSOU-TOUYA Sandrine
Original Assignee
Pierre Fabre Dermo-Cosmetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Dermo-Cosmetique filed Critical Pierre Fabre Dermo-Cosmetique
Publication of MX2017011028A publication Critical patent/MX2017011028A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The present invention concerns a combination of a retinoid and a diol and polyunsaturated fatty acid ester, a dermatological or dermocosmetic composition containing such a combination and use of same in the treatment of acne and the prevention of retentional lesions. The present invention also concerns a retinoid, optionally in combination with a diol and polyunsaturated fatty acid ester, for use in the prevention of retentional lesions.
MX2017011028A 2015-02-27 2016-02-29 Combination of a retinoid and a diol and polyunsaturated fatty acid ester. MX2017011028A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1551714A FR3033135B1 (en) 2015-02-27 2015-02-27 ASSOCIATION OF A RETINOID AND AN ESTER OF DIOL AND POLYUNSATURATED FATTY ACID
PCT/EP2016/054227 WO2016135340A1 (en) 2015-02-27 2016-02-29 Combination of a retinoid and a diol and polyunsaturated fatty acid ester

Publications (1)

Publication Number Publication Date
MX2017011028A true MX2017011028A (en) 2017-11-10

Family

ID=53200134

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011028A MX2017011028A (en) 2015-02-27 2016-02-29 Combination of a retinoid and a diol and polyunsaturated fatty acid ester.

Country Status (15)

Country Link
US (1) US10188625B2 (en)
EP (1) EP3261719B1 (en)
KR (1) KR20170122764A (en)
AR (1) AR103781A1 (en)
BR (1) BR112017017162A2 (en)
CA (1) CA2976605A1 (en)
ES (1) ES2839877T3 (en)
FR (1) FR3033135B1 (en)
MX (1) MX2017011028A (en)
PT (1) PT3261719T (en)
RU (1) RU2704109C2 (en)
TN (1) TN2017000363A1 (en)
TW (1) TW201639549A (en)
WO (1) WO2016135340A1 (en)
ZA (1) ZA201705670B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019068288A1 (en) 2017-10-04 2019-04-11 Berlimed International Research Gmbh Product containing active substance and active substance matrix for transdermal active substance delivery and production and use thereof and active substance matrix and production and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885595A (en) * 1996-05-13 1999-03-23 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic composition with a retinol fatty acid ester
US6521237B2 (en) * 1998-11-12 2003-02-18 Johnson & Johnson Consumer Companies, Inc. Skin care composition
US20080139518A1 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
FR2940281B1 (en) 2008-12-22 2011-04-01 Fabre Pierre Dermo Cosmetique ESTER OF DIOL AND POLYUNSATURATED FATTY ACID AS ANTI-ACNE AGENT
FR2940907B1 (en) * 2009-01-15 2011-03-04 Oreal COSMETIC OR DERMATOLOGICAL COMPOSITION, COMPRISING A RETINOID, A NON-PHOSPHATE COMPOUND BASED ON ADENOSINE AND A SEMI-CRYSTALLINE POLYMER

Also Published As

Publication number Publication date
KR20170122764A (en) 2017-11-06
FR3033135B1 (en) 2018-03-16
EP3261719B1 (en) 2020-09-30
ES2839877T3 (en) 2021-07-06
AR103781A1 (en) 2017-05-31
EP3261719A1 (en) 2018-01-03
US20180036275A1 (en) 2018-02-08
WO2016135340A1 (en) 2016-09-01
ZA201705670B (en) 2019-03-27
TW201639549A (en) 2016-11-16
FR3033135A1 (en) 2016-09-02
PT3261719T (en) 2021-01-05
RU2017131342A3 (en) 2019-05-17
CA2976605A1 (en) 2016-09-01
RU2017131342A (en) 2019-03-28
US10188625B2 (en) 2019-01-29
RU2704109C2 (en) 2019-10-24
BR112017017162A2 (en) 2018-04-03
TN2017000363A1 (en) 2019-01-16

Similar Documents

Publication Publication Date Title
SG10201907660YA (en) Use of short chain fatty acids in cancer prevention
PH12018500029A1 (en) Microbiome-compatible cosmetics
MX2016016761A (en) Method of treating hair with a concentrated conditioner.
MX2012010253A (en) Compositions and methods for treating and/or preventing cardiovascular disease.
PH12018500659A1 (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
WO2014111811A8 (en) Veterinary supplements
MY187945A (en) Improved mouthwash preparation
EP3296308A4 (en) Dextrin fatty acid ester and cosmetic
EP2560633A4 (en) Intravenous omega-3 fatty acid compositions & method of use
PH12017502403A1 (en) Musk composition and methods of use thereof
ZA201702385B (en) Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
MX2018006868A (en) Composition with stabilized taste and odor.
IL276596A (en) Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
EP3261622A4 (en) Millicapsule formulations comprising polyunsaturated free fatty acids
ZA201801402B (en) SELECTED AMIDE OF γ -HYDROXYBUTYRIC ACID AND USES THEREOF IN THE TREATMENT OF ALCOHOL MISUSE
MX353580B (en) Monounsaturated fatty acid for preventing and/or treating skin complexion imperfections.
PH12016502311A1 (en) Omega-3 analogues
PL3346980T3 (en) Lipophilic cosmetic compositions containing pelargonic acid esters
EP3345986A4 (en) Free polyunsaturated fatty acid-containing composition and manufacturing method therefor
MX355668B (en) Use of a myrtle extract as an anti-biofilm agent against p. acnes.
MX2021001790A (en) Solid compositions of triglycerides and uses thereof.
MX370990B (en) Esters of oligo-hydroxycarboxylic acids and use thereof.
TN2017000363A1 (en) Combination of a retinoid and a diol and polyunsaturated fatty acid ester
EP3787614A4 (en) Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
MY184483A (en) Ginsenoside fatty acid ester compound, method for preparing same, and cosmetic composition comprising same